DNASE1L3 and systemic lupus erythematosus: Recently, a novel bioenzyme with dual DNase1/DNase1L3 activity has shown significant effects in murine lupus models, effectively suppressing autoantibody production and resisting neutralization by autoantibodies in SLE patients (155).